Opposing views or like-minded? International Working Group and Alzheimer’s Association criteria
The 2024 AA and IWG diagnostic criteria for Alzheimer’s disease differ in their classification of asymptomatic individuals. Verberk et al. argue, however, that their shared requirement for biomarker use in diagnosis means they are now largely aligned, marking a pivotal step towards precision medicine in dementia care.
Authors
- Argonde C. van Harten (ORCID: https://orcid.org/0000-0002-1477-8724)
- Wiesje M. van der Flier (ORCID: https://orcid.org/0000-0001-8766-6224)
- Inge M.W. Verberk (ORCID: https://orcid.org/0000-0003-0341-7445)
Institutions
- Amsterdam Neuroscience (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Brain
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1093/brain/awaf366
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Biogen
- Danone
- Eisai
- European Brain Council